Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil

2 abstracts

Abstract
Pembrolizumab (pembro) + chemotherapy (chemo) for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Updated results from the KEYNOTE-859 study.
Org: University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil, Pontifica Catholic University of Chile, Santiago, Chile, IMAT-Oncomedica, Monteria, Colombia, Trinity St. James Cancer Institute, Dublin, Ireland,
Abstract
First-line (1L) nivolumab (N) + ipilimumab (I) + chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4‑y clinical update and outcomes by tumor histologic subtype (THS).
Org: The Ohio State University Comprehensive Cancer Center, Columbus, OH, Institutul Oncologic Prof Dr Ion Chiricută and University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania, SF Nectarie Oncology Center, Craiova, Romania, Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain, L’institut du Thorax, Nantes, France,